Valuation: UCB

Market Cap 45.31B 51.7B 41.88B 38.5B 72.78B 4,988B 73.88B 501B 196B 2,440B 194B 190B 8,401B P/E 2026 *
25.5x
P/E 2027 * 20.2x
Enterprise Value 45.06B 51.42B 41.66B 38.29B 72.39B 4,962B 73.49B 498B 195B 2,427B 193B 189B 8,356B EV / Sales 2026 *
5.27x
EV / Sales 2027 * 4.46x
Free-Float
61.59%
Yield 2026 *
0.62%
Yield 2027 * 0.63%
1 day-0.54%
1 week+0.38%
Current month-9.16%
1 month-4.69%
3 months-9.81%
6 months-7.72%
Current year-0.25%
1 week 230.7
Extreme 230.7
241.2
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 169.35
Extreme 169.35
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%+0.38%+36.12%+192.81% 52.13B
-0.67%+1.15%+23.89%-6.52% 68.85B
-3.65%+34.50%+34.50%+34.50% 43.46B
-0.58%-0.23%-52.36%-53.82% 41.24B
-2.93%+0.40%+59.97%-27.79% 30.41B
-3.77%-12.86%+90.31%-52.47% 24.53B
-1.36%-0.91%+70.42%+83.86% 23.42B
+3.99%+3.12%+3.87%+200.81% 19.75B
+0.26%-1.74%+70.47%+125.19% 16.57B
-0.76%-5.97%+73.64%+134.36% 15.95B
Average -0.63%-1.45%+41.08%+63.09% 33.63B
Weighted average by Cap. -0.92%-0.69%+32.63%+50.25%

Financials

2026 *2027 *
Net sales 8.54B 9.75B 7.9B 7.26B 13.72B 941B 13.93B 94.43B 36.97B 460B 36.6B 35.8B 1,584B 9.64B 11B 8.92B 8.2B 15.49B 1,062B 15.73B 107B 41.74B 519B 41.31B 40.41B 1,788B
Net income 1.77B 2.02B 1.64B 1.5B 2.84B 195B 2.89B 19.57B 7.66B 95.34B 7.58B 7.42B 328B 2.28B 2.6B 2.11B 1.94B 3.66B 251B 3.71B 25.17B 9.85B 123B 9.75B 9.54B 422B
Net Debt -242M -276M -224M -206M -389M -26.67B -395M -2.68B -1.05B -13.05B -1.04B -1.02B -44.91B -2.32B -2.65B -2.15B -1.97B -3.73B -256B -3.79B -25.68B -10.05B -125B -9.95B -9.74B -431B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-20 €238.00 -0.54% 155,998
26-07-17 €239.30 +0.67% 93,109
26-07-16 €237.70 +0.85% 128,758
26-07-15 €235.70 +1.38% 167,608
26-07-14 €232.50 -1.32% 152,960
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
238.00EUR
Average target price
287.95EUR
Spread / Average Target
+20.99%

Quarterly revenue - Rate of surprise